KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 119 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $963,000 | -74.6% | 100,000 | -50.0% | 0.32% | -62.5% |
| Q4 2020 | $3,798,000 | -13.8% | 200,000 | -42.9% | 0.85% | -33.6% |
| Q3 2020 | $4,407,000 | +4.1% | 350,000 | 0.0% | 1.27% | +14.1% |
| Q2 2020 | $4,235,000 | +58.1% | 350,000 | 0.0% | 1.12% | +57.3% |
| Q1 2020 | $2,678,000 | -63.8% | 350,000 | -15.7% | 0.71% | -49.6% |
| Q4 2019 | $7,391,000 | +102.3% | 415,000 | +31.7% | 1.41% | +51.2% |
| Q3 2019 | $3,654,000 | -45.0% | 315,000 | +5.0% | 0.93% | -32.4% |
| Q2 2019 | $6,645,000 | -42.0% | 300,000 | -25.0% | 1.38% | -53.9% |
| Q1 2019 | $11,448,000 | +36.4% | 400,000 | -5.9% | 2.99% | -1.8% |
| Q4 2018 | $8,394,000 | +68.7% | 425,000 | +88.9% | 3.05% | +188.2% |
| Q3 2018 | $4,975,000 | – | 225,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |